Beijing Health (Holdings) Limited (2389.HK)
- Previous Close
0.065 - Open
0.063 - Bid 0.066 x --
- Ask 0.083 x --
- Day's Range
0.063 - 0.066 - 52 Week Range
0.056 - 0.107 - Volume
504,000 - Avg. Volume
1,245,595 - Market Cap (intraday)
393.82M - Beta (5Y Monthly) -0.19
- PE Ratio (TTM)
-- - EPS (TTM)
-0.010 - Earnings Date Mar 28, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Beijing Health (Holdings) Limited, an investment holding company, provides medical, health, and geriatric care related services and products in the People's Republic of China. The company engages in owning and developing general health industrial park and incubator projects; sports businesses, which includes construction of stadiums and winter theme parks; and investment business in the field of the biotechnology, pharmaceutical, medical services, and medical travel. It also offers investment management consulting, asset management services, trading of genetic care relate furniture, and property development services. The company was formerly known as Beijing Enterprises Medical and Health Industry Group Limited and changed its name to Beijing Health (Holdings) Limited in June 2021. Beijing Health (Holdings) Limited was founded in 1995 and is headquartered in Cheung Sha Wan, Hong Kong.
bjhl.com.hk170
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 2389.HK
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2389.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2389.HK
Valuation Measures
Market Cap
393.82M
Enterprise Value
62.76M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.81
Price/Book (mrq)
0.21
Enterprise Value/Revenue
0.45
Enterprise Value/EBITDA
-1.42
Financial Highlights
Profitability and Income Statement
Profit Margin
-44.09%
Return on Assets (ttm)
-1.79%
Return on Equity (ttm)
-3.01%
Revenue (ttm)
140.35M
Net Income Avi to Common (ttm)
-61.88M
Diluted EPS (ttm)
-0.010
Balance Sheet and Cash Flow
Total Cash (mrq)
335.96M
Total Debt/Equity (mrq)
0.25%
Levered Free Cash Flow (ttm)
--
Company Insights: 2389.HK
2389.HK does not have Company Insights